000028 国药一致
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额1,281,0922,937,1392,560,4311,655,1811,502,747
投资活动产生之现金流量净额(71,232)(135,435)(342,819)(455,532)(2,783,229)
筹资活动产生之现金流量净额(1,986,223)(2,407,642)(1,507,760)(1,871,641)(1,740,423)
汇率变动对现金及现金等价物的影响(1,200)(941)(1,190)391(53)
现金及现金等价物净增加/(减少)(777,564)393,121708,661(671,601)(3,020,958)
期初现金及现金等价物余额5,835,2945,442,1734,733,5125,405,1138,426,071
期末现金及现金等价物余额5,057,7315,835,2945,442,1734,733,5125,405,113